REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate Its Long Term Safety, Efficacy and Tolerability.
Clinical trial NCT04162470 · TERMINATED
Trial details
- NCT number
- NCT04162470
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-03
- Primary completion
- 2022-04-07
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.